Follow-up
Epworth sleepiness, sleep-disordered, SDB
OBSTRUCTIVE SLEEP APNEA, ADVERSE EFFECTS
The short-term results and adverse effects were described earlier [In the present analysis, the average follow-up comprised 30.1 ± 8.4 months and was similar in SDB and non-SDB groups (31.1 ± 7.4 vs. 32.0 ± 6.0 months, The number of antihypertensive drugs decreased significantly (4.4 ± 1.1 vs. 3.8 ± 1.0, At long-term follow-up, no significant changes in creatinine level (
Patient characteristics at follow-up depending on the presence of baseline sleep-disordered breathingBMI – body mass index, BP – blood pressure, SBP – systolic blood pressure, DBP – diastolic blood pressure, ESS – Epworth sleepiness scale, eGFR – estimated glomerular filtration rate, LDL – low-density lipoprotein
Changes in the indices of obstructive sleep apnea severity and body mass index